APSR2026-62

 
Late-Breaking
Submitted
Oral Presentation
AO23-002
 
 
https://storage.unitedwebnetwork.com/files/1285/1201302-46903-APSR26_AR_433544.pptx
Format: PPTX Only
 
Format: PDF Only
03. Clinical Allergy and Immunology
4

No more than 15 authors can be listed.
Please ensure the authors are listed in the right order.
If there are multiple affiliations, please use the "+" button next to "Select Country/Region" to add additional affiliation fields.

Yue Hu * Yantai Yuhuangding Hospital Department of Otorhinolaryngology, Head and Neck Surgery Yantai China
Yakui Mou - Yantai Yuhuangding Hospital Department of Otorhinolaryngology, Head and Neck Surgery Yantai China
Chao Ren - Yantai Yuhuangding Hospital Department of Otorhinolaryngology, Head and Neck Surgery Yantai China
Xicheng Song - Yantai Yuhuangding Hospital Department of Otorhinolaryngology, Head and Neck Surgery Yantai China
 
 
 
 
 
 
 
 
 
 
 
Presenting Author Details
Yue
Hu
15712927157@163.com
+8615712927157
Under 30
China
Original Research
Staphylococcus aureus-derived xanthine exacerbates allergic rhinitis-induced olfactory dysfunction through promoting Th17 cell differentiation and IL-17A production
Maximum 25 words
Abstract Content
Allergic rhinitis (AR) is a highly prevalent inflammatory disorder of the nasal mucosa, often accompanied by olfactory dysfunction (OD) that substantially impairs patients’ quality of life. While the pathogenesis of AR-related OD is complex, the role of specific microbial metabolites in regulating the local immune responses remains poorly elucidated. The present study aimed to investigate the impact of xanthine, a metabolite derived from Staphylococcus aureus (Sa), on exacerbating AR-induced OD through promoting Th17 cell differentiation and IL-17A production.
Multi-omics analyses (metabolomics, proteomics, and 16S rRNA sequencing) were performed on patients with AR, those with other chronic nasal diseases and AR murine surrogate to identify key metabolites and dominant bacteria. Sa was cultured and untargeted metabolomics of its supernatants to detect Sa-derived key metabolites. AR mice were nasally challenged with Sa supernatants or xanthine, and companions were made with chronic AR mice with OD. IL-17A neutralizing antibody treatment was used to evaluate the therapeutic effect on AR-induced OD.
Purine metabolism and xanthine were significantly enriched in AR patients and murine models, particularly in those with OD. Compared with controls, AR patients exhibited airway microbial dysbiosis, increased abundance of Staphylococcus and significant enrichment of the Staphylococcus aureus infection pathway. Untargeted metabolomics of Sa-supernatants revealed upregulated xanthine and enriched purine metabolism. Nasal challenge with Sa-supernatants or xanthine significantly exacerbated AR-induced OD by damaging the olfactory epithelium. Mechanistically, Sa-supernatant and xanthine promoted Th17 cell differentiation and IL-17A production. Neutralization of IL-17A effectively alleviated OD and protected olfactory sensory neurons, indicating a pivotal role of the IL-17A pathway in this process.
Our study uncovers a novel mechanism by which S. aureus-derived xanthine aggravates AR-induced OD via driving Th17 cell differentiation and IL-17A production, suggesting a potential therapeutic strategy targeting microbiome and cytokines for AR-related OD.
 
 
 
 
 
No
No
 
JPG or JPEG or PNG format ONLY
Allergic rhinitis, Xanthine,mirobiome-host interactions
maximum 3 keywords and no abbreviations, separated by commas
 
290